Tekla Life Sciences Investors

HQL · NYSE
Analyze with AI
$17.08−$0.06 (−0.35%)
At close:Dec 15, 2025, 8:59 PM UTC
$17.02−$0.06 (−0.35%)
After hours:Dec 15, 2025, 9:00 PM UTC
P/E TTM-40.44
P/B TTM1.25
P/S TTM24.52
Dividend Yield10.66%
EPS$2.79
Beta0.727
Valuation
PEG Ratio0.36
FCF Yield-0.21%
EV / EBITDA-10.44
Quality
ROIC0.00%
Gross Margin9.52%
Cash Conv. Ratio0.02
Growth
Revenue 3Y CAGR39.60%
FCF Growth0.00%
Safety
Net Debt / EBITDA0.00
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle115.92

Tekla Life Sciences Investors (HQL) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Tekla Life Sciences Investors (HQL) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, Tekla Life Sciences Investors (HQL) stock is trading at $17.08. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date HQL stock quotes for informed trading decisions.

What is Tekla Life Sciences Investors's market capitalization?

Tekla Life Sciences Investors (HQL) has a market capitalization of approximately $493.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Tekla Life Sciences Investors's size relative to other companies in the USD market. The market cap figure updates automatically as the HQL stock price changes.

What is the 52-week range for Tekla Life Sciences Investors stock?

Tekla Life Sciences Investors (HQL) stock has traded in a 52-week range of $10.55 — $17.80. The 52-week range shows the highest and lowest prices at which HQL traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Tekla Life Sciences Investors stock price to this range provides context for recent price action.

How much trading volume does Tekla Life Sciences Investors stock have?

Tekla Life Sciences Investors (HQL) stock recently traded approximately 53.3K shares. Trading volume indicates market liquidity and investor interest in HQL. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Tekla Life Sciences Investors stock.

Does Tekla Life Sciences Investors pay dividends to shareholders?

Yes, Tekla Life Sciences Investors (HQL) currently offers a dividend yield of approximately 10.66%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Tekla Life Sciences Investors stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Tekla Life Sciences Investors's intraday price range?

Today, Tekla Life Sciences Investors (HQL) stock has traded in a range of $16.95 — $17.14. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring HQL's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Tekla Life Sciences Investors stock data?

AlphaPilot sources real-time HQL stock quotes, fundamental financial data, and historical price charts for Tekla Life Sciences Investors from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Tekla Life Sciences Investors stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of HQL stock performance.